Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J. Kitange(University of California, San Francisco), Jann N. Sarkaria(Mayo Clinic)
Cited by 386
Related Papers
PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel
|Clinical Cancer Research|2008|60